SHORTCAST: Tumor Intrinsic and Extrinsic Factors Determining Success of Immunotherapy

This presentation, highlights a) how the proprietary gene expression signatures were generated and validated, b) robustness of our gene signatures compared to other existing methods in identifying cell types of interest c) utility of the OncoPeptTUME in defining immunogenicity ( via immune score assignments) of tumors and predicting prognosis and long-term survival benefits based on the immune signatures of the tumors.